1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
3.4 Market Share of Top Players
4. Market Drivers
4.1 Chronic and Infectious Diseases
4.2 New Technologies
4.3 Emerging Markets
4.4 Diversifying Applications
4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2012
5.1 Point of Care Diagnostics
5.2 Clinical Chemistry and Immunochemistry
5.3 Molecular Diagnostics
5.4 Microbiology
5.5 Hemostasis
5.6 Hematology
5.7 Immunohematology
6. Segmentation by Indication (Current and Future Scenario - 2012)
6.1 Diabetes
6.2 Cardiovascular
6.3 Cancer
6.4 HIV
6.5 Tuberculosis
6.6 Influenza
7. Geographical Segmentation (Current and Future Scenario - 2012)
7.1 North America
7.1.1 United States
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 United Kingdom
7.2.5 Spain
7.2.6 Other European Countries
7.3 Japan
7.4 Rest of the World
7.4.1 China
7.4.2 India
7.4.3 Turkey
7.4.4 Brazil
7.4.5 Mexico
8. Roadblocks
8.1 Regulatory and Reimbursement Issues
8.2 R&D and Short Product Lifecycle
9. Key Player Profiles
9.1 Roche Holding Ltd.
9.2 Abbott Laboratories
9.3 Siemens AG
9.4 Beckman Coulter
9.5 Ortho-Clinical Diagnostics
